Search Results - "Tribolet, Nicolas De"

Refine Results
  1. 1

    Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1 by ALBERTONI, Michele, SHAW, Phillip H, VAN MEIR, Erwin G, HEGI, Monika E, NOZAKI, Michimasa, GODARD, Sophie, TENAN, Mirna, HAMOU, Marie-France, FAIRLIE, Douglas W, BREIT, Samuel N, PARALKAR, Vishwas M, DE TRIBOLET, Nicolas

    Published in Oncogene (20-06-2002)
    “…Human astrocytic brain tumors select for mutations in the p53 tumor suppressor gene early in malignant progression. p53 is activated upon various kinds of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients by Gsponer, J, De Tribolet, N, Déruaz, J P, Janzer, R, Uské, A, Mirimanoff, R O, Reymond, M J, Rey, F, Temler, E, Gaillard, R C, Gomez, F

    Published in Medicine (Baltimore) (01-07-1999)
    “…We reviewed the clinical features, essential laboratory data, pituitary imaging findings (computerized tomography and magnetic resonance imaging), management,…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Surgery for large vestibular schwannomas : how patients and surgeons perceive quality of life by NICOUCAR, Keyvan, MOMJIAN, Shahan, VADER, John-Paul, DE TRIBOLET, Nicolas

    Published in Journal of neurosurgery (01-08-2006)
    “…The aim of this study was to assess the consequences of total removal of a large vestibular schwannoma on the patient's symptoms and quality of life (QOL). A…”
    Get full text
    Journal Article
  7. 7

    Shunt-dependent hydrocephalus after rupture of intracranial aneurysms: a prospective study of the influence of treatment modality by DEHDASHTI, Amir R, RILLIET, Bénédict, RUFENACHT, Daniel A, DE TRIBOLET, Nicolas

    Published in Journal of neurosurgery (01-09-2004)
    “…This study was designed to determine whether the frequency of shunt-dependent hydrocephalus in patients suffering from aneurysmal subarachnoid hemorrhage (SAH)…”
    Get full text
    Journal Article
  8. 8

    FRONTOBASAL INTERHEMISPHERIC TRANS-LAMINA TERMINALIS APPROACH FOR SUPRASELLAR LESIONS by Dehdashti, Amir R., de Tribolet, Nicolas

    Published in Neurosurgery (01-06-2008)
    “…The frontobasal interhemispheric approach for suprasellar tumors currently incorporates technological advancements and refinements in patient selection,…”
    Get full text
    Journal Article
  9. 9

    Intracranial aneurysm stenting: Follow-up with MR angiography by Lövblad, Karl-Olof, Yilmaz, Hasan, Chouiter, Amine, Ruiz, Diego San Millan, Abdo, German, Bijlenga, Philippe, Tribolet, Nicolas de, Ruefenacht, Daniel A

    Published in Journal of magnetic resonance imaging (01-08-2006)
    “…Intracranial stenting is increasingly being used to treat intracranial aneurysms and stenoses. We wanted to assess the utility of magnetic resonance…”
    Get full text
    Journal Article
  10. 10

    Dissecting aneurysms of the posterior inferior cerebellar artery: report of four cases and review of the literature by Dinichert, Antoine, Rüfenacht, Daniel A., Tribolet, Nicolas de

    Published in Journal of clinical neuroscience (01-11-2000)
    “…Dissecting aneurysms frequently involve the vertebral arteries and their branches, but those exclusively on the posterior inferior cerebellar artery (PICA)…”
    Get full text
    Journal Article
  11. 11

    Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis by Desbaillets, I, Diserens, A C, Tribolet, N, Hamou, M F, Van Meir, E G

    Published in The Journal of experimental medicine (20-10-1997)
    “…Leukocyte infiltration and necrosis are two biological phenomena associated with the development of neovascularization during the malignant progression of…”
    Get full text
    Journal Article
  12. 12

    Cervical sympathetic block to reverse delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhage by Treggiari, Miriam M, Romand, Jacques-André, Martin, Jean-Baptiste, Reverdin, Alain, Rüfenacht, Daniel A, de Tribolet, Nicolas

    Published in Stroke (1970) (01-04-2003)
    “…The purpose of the present study was to evaluate the feasibility and safety of a locoregional cervical sympathetic block to improve cerebral perfusion in…”
    Get full text
    Journal Article
  13. 13

    Cutting Edge: Cross-Presentation as a Mechanism for Efficient Recruitment of Tumor-Specific CTL to the Brain by Calzascia, Thomas, Di Berardino-Besson, Wilma, Wilmotte, Rick, Masson, Frederick, Tribolet, Nicolas de, Dietrich, Pierre-Yves, Walker, Paul R

    Published in The Journal of immunology (1950) (01-09-2003)
    “…The number and localization of effector cells to the tumor site are crucial elements for immune rejection of solid tumors. However, for cerebral malignancies,…”
    Get full text
    Journal Article
  14. 14

    Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? by Dehdashti, Amir R, Mermillod, Bernadette, Rufenacht, Daniel A, Reverdin, Alain, de Tribolet, Nicolas

    “…Cerebral vasospasm is the most common cause of morbidity and mortality after aneurysmal subarachnoid hemorrhage (SAH). This study is designed to determine…”
    Get more information
    Journal Article
  15. 15

    Management of primary intracranial germinomas : diagnostic surgery or radical resection? by SAWAMURA, Y, DE TRIBOLET, N, ISHII, N, ABE, H

    Published in Journal of neurosurgery (01-08-1997)
    “…Because intracranial germinomas are readily curable with radiation and chemotherapy or radiation therapy alone, the role of radical surgery has become…”
    Get full text
    Journal Article
  16. 16

    Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells by Van Meir, Erwin G, Polverini, Peter J, Chazin, Victoria R, Su Huang, H.-J, de Tribolet, Nicolas, Cavenee, Webster K

    Published in Nature genetics (01-10-1994)
    “…The earliest genetic alteration in human astrocytoma progression is mutation of the p53 tumour suppressor gene, while one of the earliest phenotypic changes is…”
    Get full text
    Journal Article
  17. 17

    Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma by DESBAILLETS, I, DISERENS, A.-C, DE TRIBOLET, N, HAMOU, M.-F, VAN MEIR, E. G

    Published in Oncogene (18-02-1999)
    “…Oxygen deprivation is an important biological feature of tumor growth. We previously showed that in glioma, anoxia increases expression of IL-8, a chemokine…”
    Get full text
    Journal Article
  18. 18

    Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor by ISHII, N, TADA, M, HAMOU, M.-F, JANZER, R. C, MEAGHER-VILLEMURE, K, WIESTLER, O. D, DE TRIBOLET, N, VAN MEIR, E. G

    Published in Oncogene (21-10-1999)
    “…It is important to understand how low grade tumors recur and progress to malignant lesions since this dramatically shortens patient survival. Here, we…”
    Get full text
    Journal Article
  19. 19

    Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro by Desbaillets, I, Tada, M, de Tribolet, N, Diserens, A C, Hamou, M F, Van Meir, E G

    Published in International journal of cancer (15-07-1994)
    “…Expression of the monocyte chemoattractant protein-1 (MCP-1) was examined in human central nervous system tumours (glioblastomas and astrocytomas) and normal…”
    Get more information
    Journal Article
  20. 20

    INK4a/Arf is required for suppression of EGFR/ΔEGFR(2-7)-dependent ERK activation in mouse astrocytes and glioma by LACHAT, Yan, DISERENS, Annie-Claire, NOZAKI, Michimasa, KOBAYASHI, Hiroyuki, HAMOU, Marie-France, GODARD, Sophie, DE TRIBOLET, Nicolas, HEGI, Monika E

    Published in Oncogene (09-09-2004)
    “…Amplification of the epidermal growth factor receptor (EGFR) or expression of its constitutively activated mutant, ΔEGFR(2–7), in association with the…”
    Get full text
    Journal Article